Cargando…

Inadequate symptom control in advanced cancer patients across Europe

PURPOSE: The purpose of this study is to examine the adequacy of treatment for constipation, nausea, depression and poor sleep and the factors associated with inadequate symptom control in cancer patients receiving opioids. METHODS: Patients receiving strong opioids for cancer pain were recruited fr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Laugsand, Eivor A., Jakobsen, Gunnhild, Kaasa, Stein, Klepstad, Pål
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2010
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3204099/ https://www.ncbi.nlm.nih.gov/pubmed/21116653 http://dx.doi.org/10.1007/s00520-010-1051-2

Ejemplares similares

Health care providers underestimate symptom intensities of cancer patients: A multicenter European study
por: Laugsand, Eivor A, et al.
Publicado: (2010)

Genetic and Non-genetic Factors Associated With Constipation in Cancer Patients Receiving Opioids
por: Laugsand, Eivor A, et al.
Publicado: (2015)

Zopiclone versus placebo for short-term treatment of insomnia in patients with advanced cancer—a double-blind, randomized placebo-controlled clinical multicenter phase IV trial
por: Jakobsen, Gunnhild, et al.
Publicado: (2022)

The short-term impact of methylprednisolone on patient-reported sleep in patients with advanced cancer in a randomized, placebo-controlled, double-blind trial
por: Jakobsen, Gunnhild, et al.
Publicado: (2020)

Zopiclone versus placebo for short-term treatment of insomnia in patients with advanced cancer: study protocol for a double-blind, randomized, placebo-controlled, clinical multicenter trial
por: Jakobsen, Gunnhild, et al.
Publicado: (2018)

An Update on Prevalence, Assessment, and Risk Factors for Sleep Disturbances in Patients with Advanced Cancer—Implications for Health Care Providers and Clinical Research
por: Jakobsen, Gunnhild, et al.
Publicado: (2022)

Can cancer patients assess the influence of pain on functions? A randomised, controlled study of the pain interference items in the Brief Pain Inventory
por: Stenseth, Guri, et al.
Publicado: (2007)

Innate Immune Signalling Genetics of Pain, Cognitive Dysfunction and Sickness Symptoms in Cancer Pain Patients Treated with Transdermal Fentanyl
por: Barratt, Daniel T., et al.
Publicado: (2015)

The relationship between pro-inflammatory cytokines and pain, appetite and fatigue in patients with advanced cancer
por: Paulsen, Ørnulf, et al.
Publicado: (2017)

Pain Intensity Factors Changing Breakthrough Pain Prevalence in Patients with Advanced Cancer: A Secondary Analysis of a Cross-Sectional Observational International Study
por: Løhre, Erik Torbjørn, et al.
Publicado: (2018)

Antibiotic Therapy in Integrated Oncology and Palliative Cancer Care: An Observational Study
por: Moen, Martine Kjølberg, et al.
Publicado: (2022)

Genetic variation and cognitive dysfunction in opioid‐treated patients with cancer
por: Kurita, Geana Paula, et al.
Publicado: (2016)

Genetic variation in the Catechol-O-Methyltransferase (COMT) gene and morphine requirements in cancer patients with pain
por: Rakvåg, Trude T, et al.
Publicado: (2008)

Benefits of Study Participation for Patients with Advanced Cancer Receiving Radiotherapy: A Prospective Observational Study
por: Bye, Asta, et al.
Publicado: (2022)

Emergency Palliative Cancer Care: Dexmedetomidine Treatment Experiences—A Retrospective Brief Report on Nine Consecutive Cases
por: Løhre, Erik Torbjørn, et al.
Publicado: (2023)

An exploratory study examining the relationship between performance status and systemic inflammation frameworks and cytokine profiles in patients with advanced cancer
por: Dolan, Ross D., et al.
Publicado: (2019)

Influences on the pharmacokinetics of oxycodone: a multicentre cross-sectional study in 439 adult cancer patients
por: Andreassen, Trine Naalsund, et al.
Publicado: (2010)

Management of a life-threatening intercostal artery bleeding, difficult to visualize in open surgery: a case report
por: Laugsand, Eivor Alette, et al.
Publicado: (2020)

Day-to-day variations during clinical drug monitoring of morphine, morphine-3-glucuronide and morphine-6-glucuronide serum concentrations in cancer patients. A prospective observational study
por: Klepstad, Pål, et al.
Publicado: (2004)

DNA methylation markers detected in blood, stool, urine, and tissue in colorectal cancer: a systematic review of paired samples
por: Laugsand, Eivor Alette, et al.
Publicado: (2020)

Do CYP2D6 genotypes reflect oxycodone requirements for cancer patients treated for cancer pain? A cross-sectional multicentre study
por: Andreassen, Trine Naalsund, et al.
Publicado: (2011)

Interventions and symptom relief in hospital palliative cancer care: results from a prospective longitudinal study
por: Thronæs, Morten, et al.
Publicado: (2021)

Is there a genetic cause of appetite loss?—an explorative study in 1,853 cancer patients
por: Solheim, Tora S., et al.
Publicado: (2012)

Can variability in the effect of opioids on refractory breathlessness be explained by genetic factors?
por: Currow, David C, et al.
Publicado: (2015)

Risk factors for right colon, left colon and rectal cancers differ between men and women: the population‐based HUNT study in Norway
por: Brenne, Siv S., et al.
Publicado: (2022)

The N-Terminally Truncated µ3 and µ3-Like Opioid Receptors Are Transcribed from a Novel Promoter Upstream of Exon 2 in the Human OPRM1 Gene
por: Andersen, Sonja, et al.
Publicado: (2013)

Predictors and trajectory of performance status in patients with advanced cancer: A secondary data analysis of the international European Palliative Care Cancer Symptom study
por: Boland, Jason W, et al.
Publicado: (2018)

Identification of genetic polymorphisms modulating nausea and vomiting in two series of opioid-treated cancer patients
por: Colombo, Francesca, et al.
Publicado: (2020)

Social protection spending and inequalities in depressive symptoms across Europe
por: Niedzwiedz, Claire L., et al.
Publicado: (2016)

Decline of depressive symptoms in Europe: differential trends across the lifespan
por: Beller, Johannes, et al.
Publicado: (2020)

Colorectal cancer detected by liquid biopsy 2 years prior to clinical diagnosis in the HUNT study
por: Brenne, Siv S., et al.
Publicado: (2023)

Is there a genetic cause for cancer cachexia? – a clinical validation study in 1797 patients
por: Solheim, T S, et al.
Publicado: (2011)

Trajectory of health-related quality of life during the last year of life in patients with advanced non-small–cell lung cancer
por: Kristensen, Are, et al.
Publicado: (2022)

Quality of life and symptom intensity over time in people with cancer receiving palliative care: Results from the international European Palliative Care Cancer Symptom study
por: Verkissen, Mariëtte N., et al.
Publicado: (2019)

Calling for advocacy, education and public policy actions on pain control for patients with cancer in Africa
por: Krause, Rene, et al.
Publicado: (2020)

Can Reporting Heterogeneity Explain Differences in Depressive Symptoms Across Europe?
por: Kok, Renske, et al.
Publicado: (2011)

Editorial: Early palliative care for cancer patients
por: Maltoni, Marco, et al.
Publicado: (2023)

Digestive cancer screening across Europe
por: Burra, Patrizia, et al.
Publicado: (2022)

Continuous subcutaneous infusion for pain control in dying patients: experiences from a tertiary palliative care center
por: Fürst, Per, et al.
Publicado: (2020)

Moderate and severe traumatic brain injury in general hospitals: a ten-year population-based retrospective cohort study in central Norway
por: Rahim, Shavin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f7of2muidj5m2bsv6feac6tcmk